Related Experiment Video
Updated: Aug 17, 2026
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Multiple sclerosis
Abstract:
Multiple sclerosis is a chronic disease that begins in late adolescence or adulthood. It is highly variable in its expression and severity. It is believed to be autoimmune in nature. The cause is unknown; both genetic and environmental factors have been implicated in the pathogenesis. MS generally presents with the acute or subacute onset of neurologic abnormalities that may wax and wane over many years. Diagnosis is generally made by means of observation of the clinical course in conjunction with a neurologic examination and laboratory tests. These tests may include magnetic resonance imaging of the head and spine, lumbar puncture, and evoked potentials. Treatment is based on general supportive care, the use of corticosteroids for relapses, and symptomatic management of ongoing problems. The frequency of relapses can be reduced with interferon-beta (Betaseron). Copolymer 1 and interferon-beta la are being evaluated by the U.S. Food and Drug Administration for approval for use for reduction in the frequency of relapses in relapsing-remitting MS. Treatment of chronic progression is often attempted with immunosuppressive agents such as corticosteroids, azathioprine, and cyclophosphamide. Use of other agents is being investigated.
Insights
Multiple sclerosis (MS) is a chronic autoimmune disease with variable symptoms. Current treatments focus on managing relapses and symptoms, with new therapies under investigation to reduce disease progression.
Area of Science:
- Neurology
- Immunology
- Chronic Disease Research
Background:
- Multiple sclerosis (MS) is a chronic, autoimmune disease affecting young adults.
- Its etiology involves unknown genetic and environmental factors.
- MS presents with unpredictable neurological symptoms over many years.
Purpose of the Study:
- To summarize the current understanding of multiple sclerosis.
- To outline diagnostic methods and treatment strategies for MS.
- To highlight ongoing research for new MS therapies.
Main Methods:
- Diagnosis relies on clinical observation, neurological exams, and tests like MRI, lumbar puncture, and evoked potentials.
- Treatment includes supportive care, corticosteroids for relapses, and symptomatic management.
- Immunosuppressants and disease-modifying therapies like interferon-beta are used.
Main Results:
- Interferon-beta can reduce relapse frequency in relapsing-remitting MS.
- New agents, including copolymer 1 and interferon-beta 1a, are under FDA review.
- Immunosuppressive agents are used for chronic progression, with further research ongoing.
Conclusions:
- MS management involves a combination of supportive, symptomatic, and disease-modifying treatments.
- Ongoing research aims to improve treatment efficacy and address chronic progression.
- Early diagnosis and tailored treatment are crucial for managing MS.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:28Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:19Multiple Sclerosis l: Introduction
01:22Myasthenia Gravis ll: Pathophysiology